Clarissa Giebel highlights a recent RCT, which concludes that antipsychotic use by people with dementia in nursing homes can be effectively reduced through the use of a review protocol, which includes regular scrutiny of prescriptions and targeted education for physicians and nurses.
[read the full story...]Can higher educational attainment help lower dementia risk?
Raluca Lucacel summarises a recent meta-analysis of prospective cohort studies, which investigates the dose-response between education and the risk of dementia.
[read the full story...]Decision making among male carers of people with dementia
Jeanne Carlin explores a study on decision making in male carers of people with dementia and reflects on her own experiences in interpreting the findings.
[read the full story...]Psychotherapies for depression and anxiety in dementia
Clarissa Giebel summarises a recent systematic review that investigates the effectiveness of various psychotherapies (CBT, interpersonal therapy, counselling) for depression and anxiety in people with dementia or mild cognitive impairment.
[read the full story...]Dementia day programmes: how can we tell if they are effective?
Caroline Struthers looks at a study on the effectiveness of a NZ dementia day programme but wonders about the use of outcomes measures in the research.
[read the full story...]Impacts of special care unit for older adults with learning disabilities and dementia evaluated over three years
People with learning disability may be more likely to develop dementia than other people.
Here Ros Hithersay looks at the findings of a three year evaluation of a special care unit for people with dementia.
[read the full story...]Care worker experiences of dementia care in nursing and residential settings
Jo Moriarty examines research on care worker experiences of supporting people with dementia in residential settings and discovers the value of relationships in a task centred working environment.
[read the full story...]Rivastigmine for Alzheimer’s: is a small cognitive ‘improvement’ worth the risk of feeling physically unwell?
Rosalyn Nelson presents the latest Cochrane systematic review of Rivastigmine for Alzheimer’s disease, which brings together the results of 7 industry sponsored or funded trials, and concludes that Rivastigmine may be of benefit to people with Alzheimer’s disease.
[read the full story...]Living positively with dementia: findings from a qualitative systematic review
Clarissa Giebel finds a lot to discuss in a recent qualitative systematic review about living positively with dementia.
[read the full story...]German lessons for dementia care mapping in England?
Clarissa Giebel assesses a study from her native Germany into the effectiveness of dementia care mapping for improving quality of life in nursing homes.
[read the full story...]